Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Posttranslational modification of proteins by the addition of the small protein SUMO (see SUMO1\; MIM 601912), or sumoylation, regulates protein structure and intracellular localization. Zusätzlich bieten wir Ihnen SAE1 Antikörper (131) und SAE1 Proteine (19) und viele weitere Produktgruppen zu diesem Protein an.
Showing 6 out of 11 products:
Study demonstrate that CdGAP acts as a novel co-transcriptional repressor with Zeb2 (zeige ZEB2 ELISA Kits) to suppress E-cadherin (zeige CDH1 ELISA Kits) expression in breast cancer cells.
the expression of SENP8 (zeige SENP8 ELISA Kits), SAE1, PIAS1 (zeige PIAS1 ELISA Kits), PIAS2 (zeige PIAS2 ELISA Kits) and ZMIZ1 (zeige ZMIZ1 ELISA Kits) is deregulated in the majority of PTC (zeige F9 ELISA Kits) tissues, likely contributing to the PTC (zeige F9 ELISA Kits) phenotype.
as it has been shown by flow cytometry analysis, specific knockdown of SAE1 slowed down the cell population at G0/G1 phase and induced apoptosis of RKO cells.
a four-generation pedigree with isolated terminal limb defects and a truncating mutation in ARHGAP31 underscores the relevance of sequencing ARHGAP31 in cases of isolated limb defects, irrespective of presence of a complete Adams-Oliver syndrome phenotype
The focal adhesion-localized CdGAP regulates matrix rigidity sensing and durotaxis.
Data demonstrate that cdGAP negatively regulates directed and random migration by controlling adhesion maturation and dynamics through the regulation of both adhesion assembly and disassembly.
Data indicate the role of anti-SUMO activating enzyme SAE1 and SAE2 (zeige RBBP8 ELISA Kits) antibody as marker of dermatomyositis.
specific interaction between negatively charged phospholipid PI(3,4,5)P3 and the stretch of polybasic residues preceding the RhoGAP domain regulates CdGAP activity in vivo and is required for its cellular functions.
Data show that the SAE2 (zeige RBBP8 ELISA Kits) subunit of the small ubiquitin-like modifier (SUMO (zeige SUMO1 ELISA Kits)) E1 is autoSUMOylated at residue Lys (zeige LYZ ELISA Kits)-236, and SUMOylation was catalyzed by Ubc9 (zeige UBE2I ELISA Kits) at several additional Lys (zeige LYZ ELISA Kits) residues surrounding the catalytic Cys (zeige DNAJC5 ELISA Kits)-173 of SAE2 (zeige RBBP8 ELISA Kits).
loss of SAE1/2 activity drives synthetic lethality with Myc (zeige MYC ELISA Kits); inactivation of SAE2 (zeige RBBP8 ELISA Kits) leads to mitotic catastrophe and cell death upon Myc (zeige MYC ELISA Kits) hyperactivation; findings in Myc (zeige MYC ELISA Kits)-high breast cancers suggest low tumor SAE1 and SAE2 (zeige RBBP8 ELISA Kits) correlates metastasis-free survival
Posttranslational modification of proteins by the addition of the small protein SUMO (see SUMO1\; MIM 601912), or sumoylation, regulates protein structure and intracellular localization. SAE1 and UBA2 (MIM 613295) form a heterodimer that functions as a SUMO-activating enzyme for the sumoylation of proteins (Okuma et al., 1999
Cdc42 GTPase-activating protein
, rho GTPase-activating protein 31
, SUMO-1 activating enzyme E1 N subunit
, SUMO-1 activating enzyme subunit 1
, SUMO-activating enzyme subunit 1
, activator of SUMO1
, sentrin/SUMO-activating protein AOS1
, ubiquitin-like 1-activating enzyme E1A
, ubiquitin-like protein SUMO-1 activating enzyme
, ubiquitin-like (sentrin) activating enzyme E1A
, ubiquitin-like 1 (sentrin) activating enzyme E1A
, ubiquitin-like 1 (sentrin) activating enzyme subunit 1
, SUMO-activating enzyme E1 N subunit